.png)
Our Tech
We're building novel products to control and standardize 'last mile' Cell and Gene Therapy handling, preparation, and administration.
Last Mile CGT
CGT products go through a complex manufacturing process, during which they are meticulously tracked and controlled to ensure quality. Once these therapies arrive at the hospital, however, they require a series of steps that today are manual and lacking in control/standardization. This is the last mile.
The Odyssey System
We're building an automation platform to introduce standardization and simplicity to this last mile process, while lowering costs. Our platform gives CGT developers control over how their drugs are delivered to patients, and increases the pace of new site onboarding and patient enrollment. For HCPs, the Odyssey System simplifies training, and reduces rote biological tasks and frees up hands for higher level work.
For the CGT Developer, this represents a link in their supply chain they don't have control over, and are at the mercy of the Healthcare Provider (HCP) and the variable skillsets and medical equipment at each site.
HCPs, on the other hand, are having troubling training and maintaining the staff required to deliver these advanced therapies, and there is a coming deluge of CGT products moving through and towards clinical trials. Additionally, the overhead costs of CGT have made it unsustainable to deliver these therapies outside of research hospital settings.
Work With Us
Pilot Program/Clinical Trial Use
We're partnering with CGT developers for a pilot evaluation program to determine interest in using the Odyssey System for clinical trials and beyond.
Research/Manufacturing Platform
We're selling an open version (programmable parameters) of Odyssey to CGT developers and academic research labs as a tool for research and manufacturing process development use. This is a Research Use Only Product (not for use in humans).
Reach us at info@cellularvehicles.com to learn more.